Newgenivf Group Limited Stock Today

NIVF Stock   0.35  0.02  6.06%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 54

 
High
 
Low
Average
NewGenIvf Group is trading at 0.35 as of the 2nd of December 2024. This is a 6.06 percent up since the beginning of the trading day. The stock's lowest day price was 0.33. NewGenIvf Group has 54 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for NewGenIvf Group Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
3rd of April 2024
Classification
Health Care
NewGenIvf Group is entity of United States. It is traded as Stock on NASDAQ exchange. More on NewGenIvf Group Limited

Moving against NewGenIvf Stock

  0.56GH Guardant HealthPairCorr
  0.49ENOV Enovis CorpPairCorr
  0.43VVOS Vivos TherapeuticsPairCorr
  0.41LH LaboratoryPairCorr
  0.38OM Outset MedicalPairCorr
  0.38EMBC Embecta Corp TrendingPairCorr

NewGenIvf Stock Highlights

Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.633.1176
Way Down
Slightly volatile
Gross Profit Margin0.220.3274
Way Down
Pretty Stable
Net Debt1.1 M1.6 M
Way Down
Pretty Stable
Total Current Liabilities1.6 M2.2 M
Way Down
Slightly volatile
Non Current Liabilities Total2.3 M3.5 M
Way Down
Slightly volatile
Total Assets34.3 M21.3 M
Way Up
Slightly volatile
Total Current Assets48.2 K50.8 K
Notably Down
Slightly volatile
NewGenIvf Group can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NewGenIvf Group's financial leverage. It provides some insight into what part of NewGenIvf Group's total assets is financed by creditors.
NewGenIvf Group Limited (NIVF) is traded on NASDAQ Exchange in USA. It is located in null . NewGenIvf Group is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.09 M. NewGenIvf Group conducts business under Health Care Providers & Services sector and is part of Health Care industry. NewGenIvf Group generates negative cash flow from operations
Check NewGenIvf Group Probability Of Bankruptcy

NewGenIvf Group Historical Income Statement

View More Fundamentals

NewGenIvf Stock Against Markets

When determining whether NewGenIvf Group is a strong investment it is important to analyze NewGenIvf Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewGenIvf Group's future performance. For an informed investment choice regarding NewGenIvf Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewGenIvf Group Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.